Intranasal ED Treatments

Mavrox Delivers Vardenafil Through a Fast-Acting Nasal Spray

Mavrox is expanding intranasal ED treatments with Roxus, a prescription vardenafil medication delivered through a metered nasal spray rather than an oral tablet. By delivering the medication through the nasal membrane, Roxus bypasses the digestive tract and is designed to provide a faster onset with a lower dose. The treatment can begin working in as little as five minutes and provides an alternative for men who have difficulty swallowing pills or experience inconsistent responses to oral medications. Access requires an eligibility review by a licensed clinician.

The format gives Mavrox a way to differentiate its men’s health platform through a treatment focused on speed, convenience and spontaneity. Subscription packages also create recurring revenue opportunities while integrating prescriptions with telehealth access. As Mavrox is the exclusive U.S. telehealth platform during the initial launch, Roxus could also help attract new patients seeking alternatives to conventional ED tablets.

Image Credit: Mavrox

Intranasal Drug Delivery
Nasal membrane absorption creates room for lower-dose, fast-onset therapies that differentiate legacy medications through more convenient formats.
Telehealth-integrated Prescriptions
Combining clinician eligibility reviews with direct prescription access positions digital health platforms to own more of the patient treatment journey.
Subscription-based Men’s Health
Recurring medication packages can reshape men’s health care by blending discretion, convenience and ongoing patient retention models.

Industries Being Reshaped

Pharmaceuticals
Reformulating established active ingredients into alternative delivery systems offers patent, positioning and patient-experience advantages.
Digital Health
Exclusive telehealth distribution models provide differentiated access points for consumers seeking faster, more discreet treatment options.
Men’s Wellness
Demand for spontaneity-focused ED solutions expands opportunities for brands to modernize sensitive health categories with consumer-centric services.
SCORE
8.3 out of 10
GENDER
90% Men10% Women
MARKETTop markets: North America
GENERATION
  • Gen Z
  • Gen Alpha
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 75%
Activity 75%
Freshness 100%